Prevalence of the metabolic syndrome in patients with schizophrenia: baseline results from the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) schizophrenia trial and comparison with national estimates from NHANES III. (Q46683011)
Jump to navigation
Jump to search
scientific article published on 30 August 2005
Language | Label | Description | Also known as |
---|---|---|---|
English | Prevalence of the metabolic syndrome in patients with schizophrenia: baseline results from the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) schizophrenia trial and comparison with national estimates from NHANES III. |
scientific article published on 30 August 2005 |
Statements
1 reference
Prevalence of the metabolic syndrome in patients with schizophrenia: baseline results from the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) schizophrenia trial and comparison with national estimates from NHANES III. (English)
1 reference
1 reference
Jeffrey A Lieberman
1 reference
Donald C Goff
1 reference
Henry A Nasrallah
1 reference
Joseph P McEvoy
1 reference
Jonathan M Meyer
1 reference
Sonia M Davis
1 reference
Herbert Y Meltzer
1 reference
John Hsiao
1 reference
T Scott Stroup
1 reference
30 August 2005
1 reference
80
1 reference
1
1 reference
19-32
1 reference
Identifiers
1 reference